|
Phase II Data On Reslizumab Suggest Compound Improves Asthma Control And Lung …
Biomed Middle East Phase II data presented on a new investigational compound called reslizumab suggest a trend toward improvement in asthma control associated with a … |
View full post on asthma – Google News